CORC

浏览/检索结果: 共141条,第1-10条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:43/0  |  提交时间:2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:34/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:36/0  |  提交时间:2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:32/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:29/0  |  提交时间:2019/12/05
CLINICAL CHARACTERISTICS OF CHINESE PATIENTS WITH SYSTEMIC VASCULITIS: DATA FROM ONE CENTER OF THE CHINESE REGISTRY FOR SYSTEMIC VASCULITIS 会议论文
RHEUMATOLOGY, 2019-03-01
作者:  Li, Jing;  Tian, Jun;  Zheng, Wenjie;  Yang, Yunjiao;  Zhao, Jiuliang
收藏  |  浏览/下载:6/0  |  提交时间:2020/01/03
SATISFACTION OF PATIENTS AND PHYSICIANS WITH TREATMENTS FOR RHEUMATOID ARTHRITIS: A NATIONWIDE SURVEY IN CHINA 会议论文
ANNALS OF THE RHEUMATIC DISEASES, 2019-06-01
作者:  Jiang, Nan;  Yang, Pingting;  Liu, Shengyun;  Li Hongbin;  Wu, Lijun
收藏  |  浏览/下载:29/0  |  提交时间:2020/01/03
Differences in Zwitterionic Sulfobetaine and Carboxybetaine Dextran-Based Hydrogels 会议论文
LANGMUIR, 2019-02-05
作者:  Chen, Xiaofeng;  Qju, Xia;  Hou, Minghong;  Wu, Xiaotian;  Dong, Yahao
收藏  |  浏览/下载:11/0  |  提交时间:2020/01/03
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/05
The age variation of HER2 immunohistochemistry positive rate in gastric cancer 会议论文
作者:  Qin, Yejun;  Liu, Jianping;  Li, Daiqiang;  Wang, Guoping;  Nie, Xiu
收藏  |  浏览/下载:38/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace